These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33779064)

  • 1. Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
    Gaffo AL; Calhoun DA; Rahn EJ; Oparil S; Li P; Dudenbostel T; Feig DI; Redden DT; Muntner P; Foster PJ; Biggers-Clark SR; Mudano A; Sattui SE; Saddekni MB; Bridges SL; Saag KG
    Arthritis Rheumatol; 2021 Aug; 73(8):1514-1522. PubMed ID: 33779064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
    McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
    Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.
    Saddekni MB; Saag KG; Dudenbostel T; Oparil S; Calhoun DA; Sattui SE; Feig DI; Muntner P; Redden DT; Foster PJ; Rahn EJ; Biggers SR; Li P; Gaffo AL
    Contemp Clin Trials; 2016 Sep; 50():238-44. PubMed ID: 27587282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
    Feig DI; Soletsky B; Johnson RJ
    JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PH; Souza ER
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Borgi L; McMullan C; Wohlhueter A; Curhan GC; Fisher ND; Forman JP
    Hypertension; 2017 Feb; 69(2):243-248. PubMed ID: 28028194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
    George J; Carr E; Davies J; Belch JJ; Struthers A
    Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.
    Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
    Arthritis Res Ther; 2017 Dec; 19(1):283. PubMed ID: 29268756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
    Saag KG; Fitz-Patrick D; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; Becker MA
    Arthritis Rheumatol; 2017 Jan; 69(1):203-212. PubMed ID: 27564409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.
    Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
    Bardin T; Keenan RT; Khanna PP; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; So A
    Ann Rheum Dis; 2017 May; 76(5):811-820. PubMed ID: 27821644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid reduction rectifies prehypertension in obese adolescents.
    Soletsky B; Feig DI
    Hypertension; 2012 Nov; 60(5):1148-56. PubMed ID: 23006736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular Function and Uric Acid-Lowering in Stage 3 CKD.
    Jalal DI; Decker E; Perrenoud L; Nowak KL; Bispham N; Mehta T; Smits G; You Z; Seals D; Chonchol M; Johnson RJ
    J Am Soc Nephrol; 2017 Mar; 28(3):943-952. PubMed ID: 27620990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.
    Kydd AS; Seth R; Buchbinder R; Falzon L; Edwards CJ; van der Heijde DM; Bombardier C
    J Rheumatol Suppl; 2014 Sep; 92():33-41. PubMed ID: 25180126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.